Navigation Links
3-D monitor vision test Developed for Children

Stereopsis in children older than three years will soon be assessed by a new random-dot stereotest using a 3D display and infrared oculography according to an article published in the November 2006 // issue of Investigative Ophthalmology & Visual Science (IOVS).

The study involved 56 children, 38 with various visual impairments and 18 with normal vision. Study participants were seated on their mother's lap or alone with their heads stabilized by a chin and front rest. Unlike a number of other tests, this new 3D monitor stereotest does not require disassociating glasses that children often find cumbersome. The random dot stimulus was presented on an autostereoscopic display which allows viewing of full-color 3D images. The stimulus recognition was objectively assessed using infrared photo-oculography. The overall accuracy of the test was found to be 95 percent.

If applicable to preverbal children, the new test may permit study of the development of stereovision under natural conditions since no glasses are necessary to see the stimuli. The new test may be useful for the objective measurement of the sensory outcome following the treatment of ophthalmic disorders in the pediatric age group. It is also a potential substitute for the Lang I and II Test and the Radom-dot E Test, which require verbal capabilities from the subject tested.

Source-Eurekalert
NLA
'"/>




Page: 1

Related medicine news :

1. Way to monitor blood pressure
2. Microscopic lens monitors heart problems
3. Pharmaceutical industries grant for R&D to be monitored
4. GRIP a boon for the nurses to monitor patients glucose levels.
5. FDA needs to be more vigilant in monitoring, tissue banks.
6. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
7. Satellite Imagery to monitor the Social Impact Of Geographical Changes
8. Role of fats and oils in vision care
9. Watching television for long hours could lead to agressiveness
10. Body mass index guide needs revision
11. Putting cancer risk with a vision
Post Your Comments:
(Date:12/2/2008)..., Cost and Energy Efficient Information Infrastruc...re/ -- EMC Corporation (NYSE: EMC ), the world l...ay announced that the Daughters of Charity Health ...spanning the California coast, has consolidated st...ity functions to deliver new online clinical syste...
(Date:12/2/2008)...tal is now one of only two dental,practices in De...ment,Procedure). This is the only laser gum trea...for new attachment of gum and bone tissue around t...out removing healthy tissue, maintains,the height...scomfort to the,patient, closes the periodontal p...
(Date:12/2/2008)...umber of recent public research,studies substanti...s in,overweight children, and the questionable nu...onsume. Yet one manufacturer -- Funky Monkey(TM) ...ruit products that are not only fun,and convenien...the daily fruit,servings recommended by the U.S. ...
(Date:12/2/2008)...; Flu Companion uses location-based technology to .... , Scottsdale, Ariz. (PR..., makers of Zicam® Cold Remedy, today announce...anion mobile application for the T-Mobile G1&trade...me mobile application will be released for the iPh...
Breaking Medicine News(10 mins):Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 4Health News:Barotz Dental Now Offering Laser Gum Therapy 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3Health News:Zicam Launches "Cold & Flu Companion" Mobile Application 2Health News:Zicam Launches "Cold & Flu Companion" Mobile Application 3
...shington University verified the health benefits o...o assess the potential of both categories in the m...l levels and weight loss.// The study was conduct...ere half the group was asked to follow a low fat v...
...rating condition of a leprosy centre in the capita... for either relocation or reconstruction of the fa...undation and goodwill ambassador of World Health O...hen he visited the Satya Jeevan Kushta Ashram on J...
... of New Zealand is making certain changes to asthm...e changes are bound to benefit// a significant num...of the changes include widening the access to asth...easing the choice available to patients by introdu...
...l, West Sussex was prosecuted for intentionally in...as issued to arrest him.// He failed to appear a...h Crown Court that the 47-year-old businessman wou...ing a lengthy jail sentence for inflicting bodily ...
Other Medicine News:
(Date:12/1/2008)...re/ -- New research has found that the availabilit...T) scanner in an emergency room can significantly ...a potentially life-saving treatment. Results of th...NSMC)-Salem Hospital in Salem, Mass., will be pres...cal Society of North America (RSNA). , , "T...
(Date:12/1/2008)...BIO Pte Ltd today announced the initiation of a Ph...lly-active JAK2 inhibitor, in leading medical cent...hic myelofibrosis (CIMF). , , The trial is...of SB1518 in patients with CIMF and is expected to... study will assess the safety profile and evaluate...
(Date:12/1/2008)...olicy , , ROCHESTER, Minn., Dec. 1 /PRNews...inds the use of the drug therapy etanercept ineffe...flammation of the liver caused by excessive consum...lished in the December issue of Gastroenterology ...DEO ALERT: Additional audio and video resources, i...
(Date:12/1/2008)...l/ -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX...ng,human vaccines for diseases caused by HIV-1 (H... agents, announced today that the launch of its Ph...elve sites across North and South America.,These ...ional Institutes of,Health (NIH), and the HIV Vac...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 1BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 2BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 3BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 4Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 1Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 2Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 3Emageon Reports Third Quarter 2007 Financial Results 5593 1Emageon Reports Third Quarter 2007 Financial Results 5593 2Emageon Reports Third Quarter 2007 Financial Results 5593 3Emageon Reports Third Quarter 2007 Financial Results 5593 4Emageon Reports Third Quarter 2007 Financial Results 5593 5Emageon Reports Third Quarter 2007 Financial Results 5593 6Emageon Reports Third Quarter 2007 Financial Results 5593 7Emageon Reports Third Quarter 2007 Financial Results 5593 8Emageon Reports Third Quarter 2007 Financial Results 5593 9Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 1Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 2Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 3Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 4
...dest, Most Comprehensive Survey Provides New Bench... June 21, 2007 /PRNewswire-USNewswire/ -- The,foll... -- First nationwide study of the prevalence of ...s (MRSA), a virulent multi-drug resistant organism...MRSA prevalence study findings significantly excee...
... LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Neurol...ation in the June 23 issue,of the journal The Lanc...erapy trial for Parkinson,s disease and the first ...n brain cells for any adult,neurodegenerative dise...2 patients with,advanced Parkinson,s disease demon...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6
Safety Blood Collection Sets are supplied in three packaging variations, either with or without Luer Adapter and respectively a version with Luer Adapter and Tube Holder.
Simplicity and multi-directional retraction for a broad range of abdominal procedures
Expanded system accommodates the larger patient. Fully-adjustable for any patient and any approach. Blades can be stacked on top of each other in the operative site for body wall and deeper retractio
These retractors are packaged singly ready for sterilization at your facility.
Medicine Products: